T1411 Predictors of Clinical Response from a Phase 2 Multi-Center Efficacy Trial Using Rifaximin, a Gut-Selective, Nonabsorbed Antibiotic for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome

Yehuda Ringel, Salam Zakko, Nelson L. Ferreira, Enoch Bortey, Tina Wu, Kecia Courtney, William P. Forbes, Anthony Lembo, Mark Pimentel

Gastroenterology · 2008 · 16 citations · 0 references

Concepts